These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 22197348

  • 1. Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women.
    Adolf D, Wex T, Jahn O, Riebau C, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S, Piatek S.
    Maturitas; 2012 Feb; 71(2):169-72. PubMed ID: 22197348
    [Abstract] [Full Text] [Related]

  • 2. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S, Adolf D, Wex T, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S.
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [Abstract] [Full Text] [Related]

  • 3. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
    Muñoz-Torres M, Reyes-García R, Mezquita-Raya P, Fernández-García D, Alonso G, Luna Jde D, Ruiz-Requena ME, Escobar-Jiménez F.
    Maturitas; 2009 Nov 20; 64(3):188-92. PubMed ID: 19819089
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar 20; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.
    Menopause; 2013 Jan 20; 20(1):72-8. PubMed ID: 22968256
    [Abstract] [Full Text] [Related]

  • 7. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A, Singh MM, Mishra G, Singh BP, Jain GK, Jadhav S.
    Menopause; 2012 Jun 20; 19(6):642-9. PubMed ID: 22240638
    [Abstract] [Full Text] [Related]

  • 8. Relationship between bone mineral density, weight, and estrogen levels in pre and postmenopausal women.
    Corina M, Vulpoi C, Brănişteanu D.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jun 20; 116(4):946-50. PubMed ID: 23700870
    [Abstract] [Full Text] [Related]

  • 9. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb 20; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women.
    Gao LH, Li SS, Yue H, Zhang ZL.
    Front Endocrinol (Lausanne); 2020 Feb 20; 11():48. PubMed ID: 32117071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
    Menopause; 2003 Feb 20; 10(4):337-44. PubMed ID: 12851517
    [Abstract] [Full Text] [Related]

  • 14. Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years.
    Seifert-Klauss V, Fillenberg S, Schneider H, Luppa P, Mueller D, Kiechle M.
    Climacteric; 2012 Oct 20; 15(5):433-40. PubMed ID: 22443333
    [Abstract] [Full Text] [Related]

  • 15. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.
    Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS.
    Osteoporos Int; 2005 Oct 20; 16(10):1263-71. PubMed ID: 15702263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process.
    Mlakar SJ, Prezelj J, Marc J.
    Maturitas; 2012 Feb 20; 71(2):180-7. PubMed ID: 22221655
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.
    Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH.
    Clin Chim Acta; 2010 May 02; 411(9-10):771-5. PubMed ID: 20184866
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.